Return On Equity in % of Cell Source, Inc. from Q2 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cell Source, Inc. quarterly/annual Return On Equity history and change rate from Q2 2014 to Q3 2024.
  • Cell Source, Inc. Return On Equity for the quarter ending 30 Sep 2024 was 30.5 %, a 21.4% decline year-over-year.
  • Cell Source, Inc. annual Return On Equity for 2023 was 35 %, a 23.2% decline from 2022.
  • Cell Source, Inc. annual Return On Equity for 2022 was 45.6 %, a 18.6% decline from 2021.
  • Cell Source, Inc. annual Return On Equity for 2021 was 56 %, a 14.8% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Cell Source, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 30.5 -8.3 -21.4% 01 Jul 2024 30 Sep 2024
Q2 2024 31.4 -9.74 -23.7% 01 Apr 2024 30 Jun 2024
Q1 2024 31 -13.9 -31% 01 Jan 2024 31 Mar 2024
Q4 2023 35 -10.6 -23.2% 01 Oct 2023 31 Dec 2023
Q3 2023 38.8 -5.07 -11.6% 01 Jul 2023 30 Sep 2023
Q2 2023 41.1 -10 -19.6% 01 Apr 2023 30 Jun 2023
Q1 2023 44.9 -7.44 -14.2% 01 Jan 2023 31 Mar 2023
Q4 2022 45.6 -10.4 -18.6% 01 Oct 2022 31 Dec 2022
Q3 2022 43.9 -19.7 -31% 01 Jul 2022 30 Sep 2022
Q2 2022 51.1 -12.6 -19.7% 01 Apr 2022 30 Jun 2022
Q1 2022 52.4 -16.7 -24.2% 01 Jan 2022 31 Mar 2022
Q4 2021 56 -9.72 -14.8% 01 Oct 2021 31 Dec 2021
Q3 2021 63.6 +3.09 +5.11% 01 Jul 2021 30 Sep 2021
Q2 2021 63.7 -2.45 -3.7% 01 Apr 2021 30 Jun 2021
Q1 2021 69.1 +2.63 +3.96% 01 Jan 2021 31 Mar 2021
Q4 2020 65.7 -15.9 -19.5% 01 Oct 2020 31 Dec 2020
Q3 2020 60.5 -25.6 -29.7% 01 Jul 2020 30 Sep 2020
Q2 2020 66.2 +1.11 +1.71% 01 Apr 2020 30 Jun 2020
Q1 2020 66.4 +14.3 +27.4% 01 Jan 2020 31 Mar 2020
Q4 2019 81.7 +43.5 +114% 01 Oct 2019 31 Dec 2019
Q3 2019 86.1 +47.8 +125% 01 Jul 2019 30 Sep 2019
Q2 2019 65 +24 +58.3% 01 Apr 2019 30 Jun 2019
Q1 2019 52.1 +0.88 +1.72% 01 Jan 2019 31 Mar 2019
Q4 2018 38.2 -20.8 -35.2% 01 Oct 2018 31 Dec 2018
Q3 2018 38.2 +18.5 +93.5% 01 Jul 2018 30 Sep 2018
Q2 2018 41.1 +18.4 +80.9% 01 Apr 2018 30 Jun 2018
Q1 2018 51.2 +32 +166% 01 Jan 2018 31 Mar 2018
Q4 2017 58.9 +45 +324% 01 Oct 2017 31 Dec 2017
Q3 2017 19.8 -24.5 -55.4% 01 Jul 2017 30 Sep 2017
Q2 2017 22.7 -23.5 -50.8% 01 Apr 2017 30 Jun 2017
Q1 2017 19.2 -29.4 -60.4% 01 Jan 2017 31 Mar 2017
Q4 2016 13.9 -34.8 -71.5% 01 Oct 2016 31 Dec 2016
Q3 2016 44.3 -28.2 -38.9% 01 Jul 2016 30 Sep 2016
Q2 2016 46.2 -42.4 -47.9% 01 Apr 2016 30 Jun 2016
Q1 2016 48.6 -77.6 -61.5% 01 Jan 2016 31 Mar 2016
Q4 2015 48.7 -163 -76.9% 01 Oct 2015 31 Dec 2015
Q3 2015 72.5 -193 -72.7% 01 Jul 2015 30 Sep 2015
Q2 2015 88.6 -381 -81.2% 01 Apr 2015 30 Jun 2015
Q1 2015 126 01 Jan 2015 31 Mar 2015
Q4 2014 211 01 Oct 2014 31 Dec 2014
Q3 2014 265 01 Jul 2014 30 Sep 2014
Q2 2014 470 01 Apr 2014 30 Jun 2014

Cell Source, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 35 -10.6 -23.2% 01 Jan 2023 31 Dec 2023
2022 45.6 -10.4 -18.6% 01 Jan 2022 31 Dec 2022
2021 56 -9.72 -14.8% 01 Jan 2021 31 Dec 2021
2020 65.7 -15.9 -19.5% 01 Jan 2020 31 Dec 2020
2019 81.7 +43.5 +114% 01 Jan 2019 31 Dec 2019
2018 38.2 -20.8 -35.2% 01 Jan 2018 31 Dec 2018
2017 58.9 +45 +324% 01 Jan 2017 31 Dec 2017
2016 13.9 -34.8 -71.5% 01 Jan 2016 31 Dec 2016
2015 48.7 -163 -76.9% 01 Jan 2015 31 Dec 2015
2014 211 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.